Taking people in DenmarkPhase 4
Are Carvedilol and Metoprolol Succinate Comparable Treatments in Heart Failure Patients With Reduced Ejection Fraction
Key facts
- Where
- Odense C, DenmarkSee the site
- Phase
- Phase 4
Where in Denmark
- Odense University HospitalOdense C, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Odense University Hospital
- Trial code
- NCT04996550EU 2022-503010-23-01
- Record updated
- 16 August 2021
- Original description
The objective of CROWD-COMPARE is to compare the efficacy of carvedilol and metoprolol succinate on all-cause mortality or first hospitalization for worsening heart failure in patients with heart failure with reduced ejection fraction with an indication for treatment with beta-blockers.Read full original descriptionShow less
Cluster and Registry Trial of the Working Group of Heart Failure in Denmark. Are Carvedilol and Metoprolol Succinate Comparable Treatments in Heart Failure Patients With Reduced Ejection Fraction
The objective of CROWD-COMPARE is to compare the efficacy of carvedilol and metoprolol succinate on all-cause mortality or first hospitalization for worsening heart failure in patients with heart failure with reduced ejection fraction with an indication for treatment with beta-blockers.
Inclusion: Age ≥18 years; NYHA ≥ II; LVEF ≤40%.
Exclusion: No indication for beta-blocker treatment or contraindications for the two for the two study drugs (Carvedilol or metoprolol succinate).